Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00309907 · OUTCOME

C-reactive Protein Levels

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant · Source last updated 2017-09-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
mg/dL
Interval / dispersion
Standard Deviation
Time frame
From baseline to days 7, 14, 21, and 28

What was measured

Estimated mean and standard deviation

Analysis population: The data for baseline were intended to be analyzed for all subjects, therefore, combined result is reported. The data for Days 7, 14, 21 and 28 were intended to be analyzed by subgroups of subjects as pre-specified in the study protocol, therefore combined result us not reported for Etanercept + corticosteroid therapy treatment arm.

Groups in this outcome

Etanercept and Corticosteroid Therapy

Regimen A

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy28

Reported measurements

Baseline

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy24
Values in mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy28.159.1Not reportedNot reportedNot reported
Day 7 Non Responders

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy12
Values in mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy5.411.4Not reportedNot reportedNot reported
Day 7 Responders

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy10
Values in mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy1.81.9Not reportedNot reportedNot reported
Day 14 Non Responders

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy10
Values in mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy4.911.1Not reportedNot reportedNot reported
Day 14 Responders

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy8
Values in mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy11.1Not reportedNot reportedNot reported
Day 21 Non Responders

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy7
Values in mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy10.714.3Not reportedNot reportedNot reported
Day 21 Responders

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy12
Values in mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy1.62.4Not reportedNot reportedNot reported
Day 28 Non Responders

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy5
Values in mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy19.629.7Not reportedNot reportedNot reported
Day 28 Responders

Analysis denominator · Participants

GroupSource count
Etanercept and Corticosteroid Therapy14
Values in mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Etanercept and Corticosteroid Therapy5.316.1Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        59.1
        value
        28.1
    denoms
    1. counts
      1. group Id
        OG000
        value
        24
      units
      Participants
    title
    Baseline
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        11.4
        value
        5.4
    denoms
    1. counts
      1. group Id
        OG000
        value
        12
      units
      Participants
    title
    Day 7 Non Responders
  3. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.9
        value
        1.8
    denoms
    1. counts
      1. group Id
        OG000
        value
        10
      units
      Participants
    title
    Day 7 Responders
  4. categories
    1. measurements
      1. group Id
        OG000
        spread
        11.1
        value
        4.9
    denoms
    1. counts
      1. group Id
        OG000
        value
        10
      units
      Participants
    title
    Day 14 Non Responders
  5. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.1
        value
        1
    denoms
    1. counts
      1. group Id
        OG000
        value
        8
      units
      Participants
    title
    Day 14 Responders
  6. categories
    1. measurements
      1. group Id
        OG000
        spread
        14.3
        value
        10.7
    denoms
    1. counts
      1. group Id
        OG000
        value
        7
      units
      Participants
    title
    Day 21 Non Responders
  7. categories
    1. measurements
      1. group Id
        OG000
        spread
        2.4
        value
        1.6
    denoms
    1. counts
      1. group Id
        OG000
        value
        12
      units
      Participants
    title
    Day 21 Responders
  8. categories
    1. measurements
      1. group Id
        OG000
        spread
        29.7
        value
        19.6
    denoms
    1. counts
      1. group Id
        OG000
        value
        5
      units
      Participants
    title
    Day 28 Non Responders
  9. categories
    1. measurements
      1. group Id
        OG000
        spread
        16.1
        value
        5.3
    denoms
    1. counts
      1. group Id
        OG000
        value
        14
      units
      Participants
    title
    Day 28 Responders
denoms
  1. counts
    1. group Id
      OG000
      value
      28
    units
    Participants
description
Estimated mean and standard deviation
dispersion Type
Standard Deviation
groups
  1. description
    Regimen A
    id
    OG000
    title
    Etanercept and Corticosteroid Therapy
param Type
MEAN
population Description
The data for baseline were intended to be analyzed for all subjects, therefore, combined result is reported. The data for Days 7, 14, 21 and 28 were intended to be analyzed by subgroups of subjects as pre-specified in the study protocol, therefore combined result us not reported for Etanercept + corticosteroid therapy treatment arm.
reporting Status
POSTED
time Frame
From baseline to days 7, 14, 21, and 28
title
C-reactive Protein Levels
type
SECONDARY
unit Of Measure
mg/dL

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice